Kevin Tang, Director at Aurinia Pharmaceuticals Inc. (AUPH), bought 2,052,682 shares at $7.97 ($16.3M) on 2025-03-03, disclosed to the SEC on 2025-03-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.85 | 399,280 | $3.1M | 19.2% |
| 2 | $7.97 | 100,720 | $803K | 4.9% |
| 3 | $7.97 | 100,720 | $803K | 4.9% |
| 4 | $8.02 | 351,962 | $2.8M | 17.3% |
| 5 | $8.02 | 351,962 | $2.8M | 17.3% |
| 6 | $7.92 | 500,000 |
| $4.0M |
| 24.2% |
| 7 | $8.00 | 148,038 | $1.2M | 7.2% |
| 8 | $8.09 | 100,000 | $809K | 5.0% |
| Total | $7.96 avg | 2,052,682 | $16.3M | 100% |
| Filing → |
| FULC | BUY | 2026-07-20 | $595K | — | Filing → |
| BOLD | BUY | 2026-07-16 | $156K | — | Filing → |
| FULC | BUY | 2026-07-15 | $891K | — | Filing → |